Therapeutics

Tacrine

Tools

Back to the Top

Overview

Name: Tacrine
Synonyms: Cognex™
Chemical Name: 1,2,3,4-tetrahydro-9-acridinamine monohydrochloride monohydrate
Therapy Type: Small Molecule (timeline)
Target Type: Cholinergic System (timeline)
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Approved)
Company: Pfizer, Shionogi Pharma

Background

Tacrine is a reversible acetylcholinesterase inhibitor. Originally developed by Warner-Lambert Co., tacrine was the first such drug to be introduced for the treatment of Alzheimer's disease in a range of countries in South America, Asia, Europe, Australia, and the United States in 1995 and 1996. Because of its liver toxicity and attendant requirement for monitoring liver function, tacrine prescriptions dropped after other acetylcholinesterase inhibitors were introduced, and its use has been largely discontinued.

Last Updated: 12 Apr 2013

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

No Available References

Further Reading

No Available Further Reading